Benzinga | Nov 5, 2020 07:09AM EST

Autolus Therapeutics Q3 EPS $(0.72) Misses $(0.71) Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.71) by 1.41 percent. This is a 18.03 percent decrease over losses of $(0.61) per share from the same period last year.